Filing Details

Accession Number:
0001209191-14-078193
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-29 16:54:35
Reporting Period:
2014-12-23
Filing Date:
2014-12-29
Accepted Time:
2014-12-29 16:54:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1294133 Inogen Inc INGN Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1201585 B Rebecca Robertson One Sansome Street
Suite 3630
San Francisco CA 94104
No No Yes No
1279592 N Barbara Lubash One Sansome Street
Suite 3630
San Francisco CA 94104
No No Yes No
1354131 Versant Venture Capital Ii, Lp One Sansome Street
Suite 3630
San Francisco CA 94104
No No Yes No
1354132 Versant Affiliates Fund Ii-A, Lp One Sansome Street
Suite 3630
San Francisco CA 94104
No No Yes No
1354307 Versant Side Fund Ii, Lp One Sansome Street
Suite 3630
San Francisco CA 94104
No No Yes No
1354345 Phd J Bradley Bolzon One Sansome Street
Suite 3630
San Francisco CA 94104
No No Yes No
1354727 Versant Ventures Ii Llc One Sansome Street
Suite 3630
San Francisco CA 94104
No No Yes No
1354802 M Charles Warden One Sansome Street
Suite 3630
San Francisco CA 94104
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-12-23 9,785 $29.74 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 31,334 Indirect See Footnote
Common Stock 14,764 Indirect See Footnote
Common Stock 2,041,988 Indirect See Footnote
Common Stock 7,946 Indirect By Lubash Moses LLC and Evan Michael Moses Trust
Common Stock 4,280 Indirect By Robertson Family Trust
Common Stock 35,446 Direct
Footnotes
  1. The shares are held by Versant Affiliates Fund II-A, L.P. ("VAF II-A"). Versant Ventures II, LLC ("VV II") serves as the sole general partner of VAF II-A. Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Ph.D., Donald B. Milder, Rebecca B. Robertson, Bradley J. Bolzon, Charles M. Warden, and Barbara N. Lubash are directors and/or members of VV II and share voting and dispositive power over the shares held by VAF II-A, however, each disclaim beneficial ownership of these shares, except to the extent of their pecuniary interest in such shares.
  2. The shares are held by Versant Side Fund II, L.P. ("VSF II"). VV II serves as the sole general partner of VSF II. Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Ph.D., Donald B. Milder, Rebecca B. Robertson, Bradley J. Bolzon, Charles M. Warden, and Barbara N. Lubash are directors and/or members of VV II and share voting and dispositive power over the shares held by VSF II, however, each disclaim beneficial ownership of these shares, except to the extent of their pecuniary interest in such shares.
  3. The shares are held by Versant Venture Capital II, L.P. ("VVC II"). VV II serves as the sole general partner of VVC II. Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Ph.D., Donald B. Milder, Rebecca B. Robertson, Bradley J. Bolzon, Charles M. Warden, and Barbara N. Lubash are directors and/or members of VV II and share voting and dispositive power over the shares held by VVC II, however, each disclaim beneficial ownership of these shares, except to the extent of their pecuniary interest in such shares.
  4. The shares are held by Lubash Moses LLC (the "LLC") for the benefit of Barbara N. Lubash. Barbara N. Lubash is a manager of the LLC.
  5. The shares are held by the Evan Michael Moses Trust for the benefit of one or more family member of Barbara Lubash.
  6. The shares are held by the Robertson Family Trust (the "Trust") for the benefit of Rebecca Robertson. Rebecca Robertson is a trustee of the Trust. The Reporting Person disclaims beneficial ownership of the shares except to the extent of her proportionate pecuniary interest therein.
  7. The shares are held by Bradley J. Bolzon.
  8. Price reflected is the weighted-average sale price for shares sold. The range of the sale prices for the transaction was $29.5 and $30.05 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  9. The shares are held by Charles M. Warden.